Skip to main content
. 2017 Oct 6;8(54):92699–92714. doi: 10.18632/oncotarget.21564

Figure 2.

Figure 2

Kaplan-Meier analysis of the progression-free survival (PFS) (A) and overall survival (OS) (B) of patients with advanced hypopharyngeal squamous cell carcinoma exhibiting positive or negative expression of PD-L1, HLA class I, and high or low CD3+, CD4+, and CD8+ TIL density. Significant differences were evaluated using a log-rank test.